Please login to the form below

Not currently logged in
Email:
Password:

Vanda Pharmaceuticals

This page shows the latest Vanda Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

BMS' Opdivo backed as melanoma therapy in EU

BMS' Opdivo backed as melanoma therapy in EU

Vanda Pharmaceuticals got the go-ahead for Hetlioz (tasimelteon) for the treatment of non-24-hour sleep wake disorder in totally blind adults - which was approved in the US last year -

Latest news

  • FDA approves sleep disorder drug for blind people FDA approves sleep disorder drug for blind people

    Vanda Pharmaceuticals wins backing for Hetlioz to improve a person’s body clock. ... Vanda Pharmaceuticals is now allowed to market its drug Hetlioz (tasimelteon) to treat a condition called non-24-hour sleep-wake disorder, which causes problems in the

  • FDA panel backs sleep pattern drug for blind FDA panel backs sleep pattern drug for blind

    Vanda’s Hetlioz intended to improve circadian rhythms in people who cannot see. ... A Food Drug and Administration (FDA) advisory committee voted unanimously to recommend approval of Vanda Pharmaceuticals' Hetlioz (tasimelteon) for non-24-hour disorder

  • Vanda withdraws EU application for schizophrenia drug Vanda withdraws EU application for schizophrenia drug

    CHMP had previously refused to back the approval of Fanaptum. Vanda Pharmaceuticals has decided to withdraw its EU marketing application for the use of Fanaptum to treat schizophrenia. ... Vanda requested a re-examination of the data last month, but has

  • FDA starts review of Lundbeck’s antipsychotic aripiprazole

    Novartis and Vanda Pharmaceuticals also have a depot formulation of iloperidone in trials which should reach the market in 2015.

  • FDA scientist charged with insider trading

    The criminal complaint charges both men with conspiracy to commit securities and wire fraud relating to their trading of stock in Clinical Data, Vanda Pharmaceuticals, Progenics Pharmaceuticals, Middlebrook Pharmaceuticals and Momenta ... Pharmaceuticals.

More from news
Approximately 3 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

The concordance conundrum: understanding the complexities of behaviour change
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....
The concordance conundrum: creating space for open dialogue
Growing numbers of patients want a partnership model with their HCP, whereby both parties are equally involved in the decision-making process. This model has been linked with an increase in...
Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...

Infographics